Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Prothena Biosciences Ltd.
Scientific Title
A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Birtamimab Plus Standard of Care vs. Placebo Plus Standard of Care in Mayo Stage IV Subjects With Light Chain (AL) Amyloidosis